Status:
TERMINATED
Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy
Lead Sponsor:
David Chi, MD
Conditions:
Adenotonsillectomy
Post-operative Analgesia
Eligibility:
All Genders
3-17 years
Phase:
PHASE1
PHASE2
Brief Summary
The goal of this study is to determine if non-opioid pain control is a safe way to manage pain after intracapsular adenotonsillectomy surgery in children. This study is the second part of our randomiz...
Detailed Description
Purpose: To determine if non-opioid pain control is a safe and effective option in the treatment of post-operative pain following intracapsular adenotonsillectomy in various pediatric age groups. Met...
Eligibility Criteria
Inclusion
- • Patients age 3 - 17 undergoing adenotonsillectomy
Exclusion
- Down syndrome
- History of coagulopathy
- Craniofacial abnormalities other than plagiocephaly or submucous cleft palate (SMCP)
- Caregivers who cannot speak, read, or write in English proficiently
- Patients who take opioids during the enrollment period
- Patients who take chronic opioids
- Pregnancy
- Allergy to or contraindication for taking any of the study medications
- Patients who have the inability to communicate
- Patients who have the inability to localize pain
Key Trial Info
Start Date :
April 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 3 2023
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT04791761
Start Date
April 13 2021
End Date
July 3 2023
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15224